“揭榜挂帅”驱动龙江刺五加产业创新突破

Core Insights - The article discusses the high-quality development of the traditional Chinese medicine industry in Heilongjiang, focusing on the "Eagle Flag" technology project for the clinical research of Schisandra chinensis products [1][2] Group 1: Project Overview - The project titled "Basic and Clinical Research of Schisandra chinensis Series Products" was recently validated by experts in Shanghai, with participation from over 260 top experts in the medical field [1] - Heilongjiang province holds over 80% of the national wild Schisandra chinensis resources, leading in patents, product varieties, and raw material processing [1] Group 2: Research and Development - The project has established a complete industrial chain from the cultivation of medicinal materials to research, production, and market promotion over the past two years [1] - A total of 658 case studies have been completed using evidence-based medicine methods to validate the clinical efficacy of the compound Schisandra chinensis granules, achieving breakthroughs in safety evaluation and pharmacological mechanisms [1] Group 3: Government and Institutional Support - The Heilongjiang Provincial Science and Technology Department is committed to enhancing innovation ecosystems and providing comprehensive support for the development of traditional Chinese medicine enterprises [2] - Local government officials emphasize the importance of building a high-end collaborative platform for research, clinical application, and results transformation of Schisandra chinensis products [2] Group 4: Future Directions - Experts call for a focus on core technology breakthroughs and enhanced collaboration between academia and industry to integrate basic research with clinical applications [2] - A cooperation agreement was signed to promote the international market presence of "Jixi Schisandra chinensis," indicating a strategic move towards global expansion [3]